文献速递主动脉疾病

胸腹主动脉瘤开窗分支腔内修复术中单阶段与多阶段策略的比较

Comparison of single- and multistage strategies during fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2023-01-31

本研究比较了广泛胸腹主动脉瘤(TAAA)开窗分支腔内修复术(FB-EVAR)中单阶段与多阶段策略的结局。多阶段策略更常用于择期修复,在倾向性评分调整后与较低的30天/住院期间死亡和/或永久性截瘫风险以及较高的1年和3年患者生存率相关。

要点

  • 择期FB-EVAR中,多阶段策略较单阶段与较低的30天/住院死亡和/或永久性截瘫率相关。
  • 倾向性评分调整后,多阶段策略与较高的1年和3年患者生存率相关。
  • 多阶段策略在择期修复中比非择期修复中更常用(55% vs 35%)。

核心结论

  • 择期I至III型TAAA的FB-EVAR中,分期策略与30天或住院期间死亡和/或永久性截瘫风险降低相关,并与较高的1年和3年患者生存率相关。

研究设计与样本

  • 研究为多中心回顾性队列研究,纳入24个中心2006年至2021年连续接受FB-EVAR治疗I至III型TAAA的患者。
  • 共纳入1947例患者(65%男性;平均年龄71±8岁),其中I型155例(10%)、II型729例(46%)、III型713例(44%)。
  • 单阶段策略939例(48%),多阶段策略1008例(52%)。
  • 分期策略包括近端胸主动脉修复、微创节段动脉弹簧圈栓塞、临时瘤囊灌注及其组合。

主要发现

  • 多阶段策略在择期修复中比非择期修复中更常用(55% vs 35%;P < .001)。
  • 择期修复患者(n = 1597)中,30天/住院期间死亡和/或永久性截瘫复合终点发生率单阶段组为14%,多阶段组为6%(P < .001)。
  • 倾向性评分调整后,多阶段策略与较低的30天/住院期间死亡和/或永久性截瘫率相关(比值比,0.466;95%置信区间,0.271-0.801;P = .006)。
  • 倾向性评分调整后,多阶段策略与较高的1年患者生存率(86.9±1.3% vs 79.6±1.7%)和3年患者生存率(72.7±2.1% vs 64.2±2.3%;调整风险比,0.714;95%置信区间,0.528-0.966;P = .029)相关。

临床怎么用

  • 作者认为,择期I至III型TAAA的FB-EVAR可采用分期策略以降低30天或住院期间死亡和/或永久性截瘫风险并提高1年和3年生存率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare outcomes of single or multistage approach during fenestrated-branched endovascular aortic repair (FB-EVAR) of extensive thoracoabdominal aortic aneurysms (TAAAs). METHODS: We reviewed the clinical data of consecutive patients treated by FB-EVAR for extent I to III TAAAs in 24 centers (2006-2021). All patients received a single brand manufactured patient-specific or off-the-shelf fenestrated-branched stent grafts. Staging strategies included proximal thoracic aortic repair, minimally invasive segmental artery coil embolization, temporary aneurysm sac perfusion and combinations of these techniques. Endpoints were analyzed for elective repair in patients who had a single- or multistage approach before and after propensity score adjustment for baseline differences, including the composite 30-day/in-hospital mortality and/or permanent paraplegia, major adverse event, patient survival, and freedom from aortic-related mortality. RESULTS: A total of 1947 patients (65% male; mean age, 71 ± 8 years) underwent FB-EVAR of 155 extent I (10%), 729 extent II (46%), and 713 extent III TAAAs (44%). A single-stage approach was used in 939 patients (48%) and a multistage approach in 1008 patients (52%). A multistage approach was more frequently used in patients undergoing elective compared with non-elective repair (55% vs 35%; P < .001). Staging strategies were proximal thoracic aortic repair in 743 patients (74%), temporary aneurysm sac perfusion in 128 (13%), minimally invasive segmental artery coil embolization in 10 (1%), and combinations in 127 (12%). Among patients undergoing elective repair (n = 1597), the composite endpoint of 30-day/in-hospital mortality and/or permanent paraplegia rate occurred in 14% of single-stage and 6% of multistage approach patients (P < .001). After adjustment with a propensity score, multistage approach was associated with lower rates of 30-day/in-hospital mortality and/or permanent paraplegia (odds ratio, 0.466; 95% confidence interval, 0.271-0.801; P = .006) and higher patient survival at 1 year (86.9±1.3% vs 79.6±1.7%) and 3 years (72.7±2.1% vs 64.2±2.3%; adjusted hazard ratio, 0.714; 95% confidence interval, 0.528-0.966; P = .029), compared with a single stage approach. CONCLUSIONS: Staging elective FB-EVAR of extent I to III TAAAs was associated with decreased risk of mortality and/or permanent paraplegia at 30 days or within hospital stay, and with higher patient survival at 1 and 3 years.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dias-Neto M, Tenorio ER, Huang Y, et al. Comparison of single- and multistage strategies during fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms. J Vasc Surg. 2023. PMID: 36731757. doi:10.1016/j.jvs.2023.01.188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。